| Nichole Lachance, CCC | |
|
4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5212 | |
| (907) 336-7323 | |
| (907) 277-7355 |
| Full Name | Nichole Lachance |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4050 Lake Otis Pkwy, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326100629 | NPI | - | NPPES |
| SP6595 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 90 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nichole Lachance, CCC 4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5212 Ph: (907) 336-7323 | Nichole Lachance, CCC 4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5212 Ph: (907) 336-7323 |
News Archive
The results of the first trial to administer the polypill on the basis of age alone has shown the largest reductions in blood pressure and cholesterol level of any polypill trial to date, researchers report.
Women who have high blood levels of a hormone called insulin-like growth factor-I are more likely to develop breast cancer, according to a Cancer Research UK study published in the Lancet Oncology today (Monday).
Dainippon Sumitomo Pharma Co., Ltd. ("DSP") and Sepracor Inc. today announce the successful completion of DSP's acquisition of Sepracor for US$23.00 per share in cash. DSP completed the acquisition through a cash tender offer and by exercising an option to acquire additional shares directly from Sepracor followed by a short-form merger of an indirect wholly-owned subsidiary of DSP with and into Sepracor on October 20, 2009. Sepracor is now an indirect wholly-owned subsidiary of DSP.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with the University of Pretoria as part of its industry unique Prime Site program, an initiative to accelerate the development of new and more effective medicines.
Ultromics is currently supporting multiple ongoing clinical trials including "Rainier", based in the U.S., and "EVAREST", in the UK.
› Verified 6 days ago
Kathryn Cross, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12350 Industry Way, 202, Anchorage, AK 99515 Phone: 907-301-4588 | |
Tracey Keaton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518 Phone: 907-345-0050 | |
Christal Hays, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-8800 | |
Mrs. Lisa J.c. Rayes, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4048 Laurel St Ste 303, Anchorage, AK 99508 Phone: 907-562-4550 | |
Lian Liew Tan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4155 Tudor Centre Dr, Suite #103, Anchorage, AK 99508 Phone: 907-854-8624 | |
Mrs. Yvonne Marie San Juan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4241 B St Ste 301, Anchorage, AK 99503 Phone: 907-727-0935 Fax: 907-276-7529 | |
Speak From The Heart Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3351 W 84th Ave, Anchorage, AK 99502 Phone: 907-390-0492 |